New insights into rare liver cancer as clinical trial for treatment begins
Like many rare diseases, fibrolamellar hepatocellular carcinoma (FLC) mounts a ferocious attack against an unlucky few-in this case, children, adolescents, ...
Like many rare diseases, fibrolamellar hepatocellular carcinoma (FLC) mounts a ferocious attack against an unlucky few-in this case, children, adolescents, ...
New research uncovers how distinct molecular profiles and immune signatures in metastatic pancreatic cancer impact survival and guide tailored treatment ...
Raymond Y. Huang, MD, Ph.D., of the Department of Radiology at Brigham and Women's Hospital, is the corresponding author of a ...
Tumor cells circulating in the blood are the "germ cells" of breast cancer metastases. They are very rare and could ...
Scientists at University of California San Diego School of Medicine have shed new light on the development of liver cancer, ...
In 2022 alone, over 20 million people were diagnosed with cancer, and nearly 10 million died from the disease, according ...
Early use of AHCC during hepatitis stages shows potential to reduce the risk of cirrhosis, according to new research Study: ...
Mayo Clinic announces the results of an innovative treatment approach that may offer improvement in overall survival in older patients with ...
The ZEST clinical trial, designed to evaluate niraparib (Zejula) for the prevention of breast cancer recurrence in patients with circulating ...
Prostate cancer hijacks the normal prostate's growth regulation program to release the brakes and grow freely, according to Weill Cornell ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net